The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 14, 2015

Filed:

Dec. 05, 2013
Applicants:

St. Jude Children's Research Hospital, Memphis, TN (US);

Flanders Interuniversity Institute for Biotechnology Vib, Ghent, BE;

Universiteit Gent, Ghent, BE;

Leiden University Medical Center, Leiden, NL;

Inventors:

Michael A. Dyer, Memphis, TN (US);

Jean-Christophe Marine, Erbisoeul, BE;

Aart Gerrit Jochemsen, Leiden, NL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61K 31/00 (2006.01); G01N 33/574 (2006.01); A61K 31/473 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 31/00 (2013.01); A61K 31/473 (2013.01); G01N 33/57407 (2013.01); G01N 2500/02 (2013.01); G01N 2510/00 (2013.01); G01N 2800/16 (2013.01);
Abstract

It has now been found that the p53 pathway is inactivated in ocular cancers such as retinoblastoma. As such, the present invention is a method for inducing ocular cancer cell death using a p53 activator. In particular embodiments, the p53 activator blocks the interaction between DM2 or DMX and p53. As the p53 activator induces ocular cancer cell death, a method for preventing or treating ocular cancer is also provided.


Find Patent Forward Citations

Loading…